Site Selection
Optimizing Clinical Trial Success with Ergomed’s Site Identification and Selection
Suitable site selection is a pivotal factor in the success of any clinical trial. Even the most meticulously designed protocols can only thrive with the right site selection. At Ergomed, our seasoned experts lead our country and site selection decision-making process. This process is a cornerstone of our commitment to delivering high-quality results from our clinical trials. Our data-driven approach, honed over years of experience, ensures that we pinpoint the optimal sites for your study, enhancing the likelihood of success.
Comprehensive Country-Level Feasibility Assessment
We conduct a robust country-level feasibility assessment before we begin the site identification and selection process. This initial step, part of our comprehensive service, is crucial for determining the ideal site profile and involves a collaborative effort between our feasibility, medical, regulatory, and operational experts and your team. By combining insights from these diverse fields, we create a comprehensive strategy tailored specifically to the unique needs of your clinical trial, making you feel valued and prioritized.
Data-Driven Approach to Site Identification
Data drive our site identification process. We meticulously customize our protocol-aligned feasibility questionnaire to drill down to the most minor details, each of which can significantly impact the success of your project. This thorough and data-driven approach, which leaves no stone unturned, lets us gather precise information on critical factors influencing site performance, reassuring our decision-making process.
Key Components of Our Data-Driven Site Identification:
Leveraging Clinical Trial Intelligence Tools
We harness the power of leading publicly available and licensed clinical trial intelligence tools to aid our decision-making process. These tools extract information from extensive source data, providing comprehensive data on potential sites. This wealth of information allows us to make informed decisions, ensuring your study’s best possible site selection.
Evaluating Protocol-Related Factors
We evaluate critical protocol-related factors, including access to potential participant populations, investigator experience and competence, site capabilities, and capacity. Additionally, we overlay these factors with country-level standards of care and regulatory nuances to provide a comprehensive report and recommendations. This thorough evaluation ensures we identify sites best equipped to conduct your study successfully.
Facilitating Essential Site Identification Activities
Our expert team facilitates all necessary activities to ensure a smooth and efficient identification. These comprehensive activities include:
-
We negotiate and execute CDAs to protect sensitive study information and establish confidentiality with potential sites.
-
We develop and distribute tailored questionnaires, then thoroughly assess the resulting data.
-
We perform debarment checks to ensure potential investigators are permitted to conduct clinical research.
-
We conduct visits and compile detailed reports to provide additional insights into the suitability of potential sites for study participation.
Achieve Your Clinical Trial Goals with Ergomed’s Site Identification and Selection Process
Contact us today to learn how Ergomed’s country and site selection services and our other comprehensive clinical trial services can support your clinical research needs and help you achieve your clinical trial goals.
Support for Trial Sites, Ergo, Improved Execution
Our Complementary Services
See how Ergomed can support your clinical trial.
More Ergomed Services
Find out how Ergomed supports your clinical trial objectives.
Discover Our Latest Insights
Access Ergomed's resources for the latest in clinical trial trends and innovations.